Arastoo, MohammadMazanetz, Michael P.Miller, SonyaShiells, HelenHull, ClaireRobinson, KeithStorey, John M.D.Harrington, Charles R.Wischik, Claude M.2023-11-022023-11-022023-09-06Arastoo, M, Mazanetz, M P, Miller, S, Shiells, H, Hull, C, Robinson, K, Storey, J M D, Harrington, C R & Wischik, C M 2023, 'Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine : A Prospective Study of Phase 3 Clinical Trial Participants', International Journal of Molecular Sciences, vol. 24, no. 18, 13747. https://doi.org/10.3390/ijms2418137471661-6596ORCID: /0000-0002-5261-5467/work/146067516ORCID: /0000-0002-0805-4949/work/146067800ORCID: /0000-0003-2250-3920/work/173415885https://hdl.handle.net/2164/22092Funding Information: This work was funded by TauRx Therapeutics Ltd., Singapore.142854430enganti-hypoxaemiaCOVID-19hydromethylthioninehypoxaemiaSARS-CoV-2RM Therapeutics. PharmacologyCatalysisMolecular BiologySpectroscopyComputer Science ApplicationsPhysical and Theoretical ChemistryOrganic ChemistryInorganic ChemistryRMJournal article10.3390/ijms241813747http://www.scopus.com/inward/record.url?scp=85172769943&partnerID=8YFLogxK2418